---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

——————

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):  December 16, 2015

(Exact name of registrant as specified in its charter)

Utah	0-12697	87-0398434
(State or Other Jurisdiction of Incorporation)	Commission File Number	(IRS Employer Identification Number)

7030 Park Centre Dr., Salt Lake City, Utah                            84121
(Address of principal executive offices)                            (Zip Code)

Registrant's telephone number, including area code: (801) 568-7000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

In connection with the closing of the private placement of preferred stock reported previously by Dynatronics Corporation ("Registrant") in a Current Report on Form 8-K filed on July 1, 2015, on December 16, 2015 Registrant appointed David B. Holtz as a Preferred Director nominated by the holders of the Registrant's Series A 8% Convertible Preferred Stock (the "Preferred Stock").  The holders of the Preferred Stock have the right to appoint up to three members of the Registrant's board of directors. The appointment of Mr. Holz brings the number of Preferred Directors on the board to three and the total number of directors of the Registrant to seven.  The other two Preferred Directors are Erin S. Enright and Brian M. Larkin.

Mr. Holtz, age 49, has held a number of important positions in the healthcare industry and other industries throughout his career, which the Registrant believes qualify him to serve on Registrant's board of directors. He currently serves on the executive management team of Provco Group Ltd., a family business responsible for the management of a portfolio of public and private equity portfolios and fund investments.  Provco is the beneficial owner of 400,000 shares of Preferred Stock and consequently is the beneficial owner of 1,000,000 shares (or 30.8%) of the Registrant's common stock assuming full conversion of 400,000 shares of Preferred Stock and the exercise of warrants for the purchase of 600,000 shares of common stock.  Prior to joining Provco Group, Mr. Holtz served as interim president and CEO of Nucryst Pharmaceuticals Corp., based in Princeton, New Jersey. From 1993 to 2006, he held various positions at Integra LifeSciences Holdings Corp. (NASDAQ: IART) in Plainsboro, New Jersey. He graduated from Susquehanna University with a bachelor's degree in business administration.

At the Annual Meeting of Shareholders of the Registrant held December 16, 2015, the shareholders elected four directors: Kelvyn H. Cullimore, Jr., Larry K. Beardall, R. Scott Ward, and Scott A. Klosterman.  Two directors of the Registrant who did not stand for election retired at the Annual Meeting: Howard L. Edwards and Richard J. Linder.  Biographical information for Mr. Klosterman is contained in the Registrant's Definitive Proxy Statement filed with the Securities and Exchange Commission on October 28, 2015.

Item 5.07                                           Submission of Matters to a Vote of Security Holders.

 

The Registrant held its Annual Meeting of Shareholders on December 16, 2015.  A total of 3,230,825 shares (approximately 83%) of the issued and outstanding shares of Registrant's common stock entitled to vote at the Annual Meeting were represented by proxy or in person at the meeting.  The following matters were submitted and voted upon at the Annual Meeting:

						Number of				Number of
		Number of				Shares				Shares				Broker Non-
Name		Shares For				Withheld				Abstaining				Votes
Kelvyn H. Cullimore, Jr.			2,112,789				35,089				—				1,082,947
Larry K. Beardall			2,038,223				109,655				—				1,082,947
R. Scott Ward			2,125,277				22,601				—				1,082,947
Scott A. Klosterman			2,130,377				17,501				—				1,082,947

Number of

Number of

Number of

Shares

Shares

Broker Non-

Shares For

Against

Abstaining

Votes

3,205,779

14,273

10,773

—

Registrant issued a press release announcing the appointment of Mr. Holtz and the election of Mr. Klosterman to the Registrant's board of directors on December 17, 2015.  A copy of the press release is furnished with this Current Report as Exhibit 99.1.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 18, 2015

---